Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-05-17
2010-12-07
Anderson, James D (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S183000, C548S530000, C548S400000
Reexamination Certificate
active
07846963
ABSTRACT:
The present invention is related to new 2-oxo-cyclic compound the process for preparing them and a pharmaceutical composition comprising the same. The present invention provides a pharmaceutical composition for preventing and treating the inflammatory disease comprising the pain or inflammation caused by rheumatic disease, for example, rheumatoid arthritis, spondyloarthopathies, gout, osteoarthritis, systemic lupus erythematosus and juvenile arthritis, and inflammatory syndrome for example, from myositis, gingivitis, synovitis, ankylosing spondylitis, burstitis, burns and scar, inflammatory Crohn's disease, Types I diabetes. therefore, it can be used as the therapeutics for treating and preventing inflammatory diseases.
REFERENCES:
patent: 5281585 (1994-01-01), Duggan
patent: 6110930 (2000-08-01), Taniguchi
patent: 6303613 (2001-10-01), McInally
patent: 6476023 (2002-11-01), Cirillo
patent: 870763 (1998-10-01), None
patent: 2268934 (1994-01-01), None
patent: 1042640 (1996-09-01), None
patent: PCT/GB89/01398 (1990-05-01), None
patent: PCT/GB92/00230 (1992-08-01), None
patent: PCT/US92/03809 (1992-10-01), None
patent: PCT/GB93/01556 (1994-03-01), None
patent: PCT/GB94/00808 (1994-10-01), None
patent: PCT/GB94/02145 (1995-04-01), None
patent: PCT/US97/00523 (1997-09-01), None
patent: WO 97/32846 (1997-09-01), None
patent: 97/36900 (1997-10-01), None
patent: 98/45294 (1998-10-01), None
J. Bone Joint Surg . 52A , pp. 424-434, 1970.
Clin. Exp. Immunol. 81 , p. 301, 1990.
Nature, 370 , p. 555, 1994.
Journal of Organic Chemistry, 1996, vol. 61, No. 7, pp. 2283-2292.
Canadian Journal of Chemistry, 1983, vol. 61, No. 9, pp. 2016-2021.
Tetrahedron Letters (1995), (No. 5), 4-9.
Lee, D. et al., alpha-Methylenelactam rearrangement, 1974, J. Org. Chem., vol. 39, No. 7, 893-902.
Hirata, T. et al., 1959, The structure of Cypridina Luciferin, Tetrahedron Letters, No. 5, pp. 4-9.
EP Search Report, Feb. 4, 2009.
Supplementary EP Search Report, Jul. 3, 2008.
Chun Hyo Kon
Chun Tae Gyu
Han Gyoon Hee
Han Sang Bae
Kho Yung Hee
Anderson James D
Finn Meghan
Hahn Kirk
Korea Research Institute of Bioscience and Biotechnology
LandOfFree
2-oxo-heterocyclic compounds and the pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-oxo-heterocyclic compounds and the pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-oxo-heterocyclic compounds and the pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4176852